Back to search
FDAFDA · Food and drugs·Recall number D-0492-2025

UNAVY ACIDO HIALURONICO, Conenido: 30 capletas de 850mg, distribuido por: EREN NATURAL S.A. DE C.V, Zappan, Jal. C.P, UPC 7 503046 054295

Published June 25, 2025 · Recall initiated: May 21, 2025

Summary

FDA records drug Class I recall D-0492-2025, published June 25, 2025 and initiated May 21, 2025. Recalling firm: Umary-USA.com; Status: Completed; Reported quantity: 1,342 30-count bottles; Lot: All Lots; All Expiration Dates. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone, Diclofenac and Omeprazole.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Umary-USA.com
Distributor
U.S. Nationwide via internet.
Lot
All Lots; All Expiration Dates.
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was UNAVY ACIDO HIALURONICO, Conenido: 30 capletas de 850mg, distribuido por: EREN NATURAL S.A. DE C.V, Zappan, Jal. C.P, UPC 7 503046 054295 recalled?

Yes. FDA published recall D-0492-2025 on June 25, 2025. Reported hazard: Marketed without approved NDA/ANDA- Laboratory analysis found product to be tainted with undeclared ingredients: Dexamethasone, Diclofenac and Omeprazole.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release